Epigenetic Regulation of Dopamine Transporter mRNA Expression in Human Neuroblastoma Cells

Neurochemical Research

Volumn 40, Issue 7, 2015, Pages 1372-1378

  Green, Ashley L ^a   Hossain, Muhammad M ^a   Tee, Siew C ^a   Zarbl, Helmut ^a   Guo, Grace L ^b   Richardson, Jason R ^a  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS UNIVERSITY   (United States)

Author keywords

Chromatin; DNA methyltransferase; Dopamine transporter; Epigenetic; Histone; Histone deacetylase inhibitor

Indexed keywords

BUTYRIC ACID; DNA METHYLTRANSFERASE 1; DOPAMINE TRANSPORTER; HISTONE DEACETYLASE 1; MESSENGER RNA; N PHTHALOYLTRYPTOPHAN; SMALL INTERFERING RNA; VALPROIC ACID; DNA METHYLTRANSFERASE; HISTONE DEACETYLASE;

ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME INHIBITION; EPIGENETICS; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; NEUROBLASTOMA; NEUROBLASTOMA CELL; PRIORITY JOURNAL; GENETIC EPIGENESIS; GENETICS; PATHOLOGY; TUMOR CELL LINE;

CELL LINE, TUMOR; DNA MODIFICATION METHYLASES; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; EPIGENESIS, GENETIC; GENE KNOCKDOWN TECHNIQUES; HISTONE DEACETYLASES; HUMANS; NEUROBLASTOMA; RNA, MESSENGER; RNA, SMALL INTERFERING;

EID: 84938200501     PISSN: 03643190     EISSN: 15736903     Source Type: Journal    
DOI: 10.1007/s11064-015-1601-6     Document Type: Article

References (36)

1. Haberland N, Hetey L (1987) Studies in postmortem dopamine uptake. II. Alterations of the synaptosomal catecholamine uptake in postmortem brain regions in schizophrenia. J Neural Transm 68:303–313
2. Cook EH Jr, Stein MA, Krasowski MD, Cox NJ, Olkon DM, Kieffer JE, Leventhal BL (1995) Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56:993–998
3. Malison RT, McDougle CJ, van Dyck CH, Scahill L, Baldwin RM, Seibyl JP, Price LH, Leckman JF, Innis RB (1995) [123I]beta-CIT SPECT imaging of striatal dopamine transporter binding in Tourette’s disorder. Am J Psychiatry 152:1359–1361
4. Giros B, Caron MG (1993) Molecular characterization of the dopamine transporter. Trends Pharmacol Sci 14:43–49
5. Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16:436–447
6. Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci USA 95:4029–4034
7. Gainetdinov RR, Caron MG (2003) Monoamine transporters: from genes to behavior. Annu Rev Pharmacol Toxicol 43:261–284
8. Giros B, Jaber M, Jones SR, Wightman RM, Caron MG (1996) Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature 379:606–612
9. Kilty JE, Lorang D, Amara SG (1991) Cloning and expression of a cocaine-sensitive rat dopamine transporter. Science 254:578–579
10. Vandenbergh DJ, Persico AM, Hawkins AL, Griffin CA, Li X, Jabs EW, Uhl GR (1992) Human dopamine transporter gene (DAT1) maps to chromosome 5p15.3 and displays a VNTR. Genomics 14:1104–1106
11. Vandenbergh DJ, Persico AM, Uhl GR (1992) A human dopamine transporter cDNA predicts reduced glycosylation, displays a novel repetitive element and provides racially-dimorphic TaqI RFLPs. Brain Res Mol Brain Res 15:161–166
12. Kouzmenko AP, Pereira AM, Singh BS (1997) Intronic sequences are involved in neural targeting of human dopamine transporter gene expression. Biochem Biophys Res Commun 240:807–811
13. Sacchetti P, Brownschidle LA, Granneman JG, Bannon MJ (1999) Characterization of the 5’-flanking region of the human dopamine transporter gene. Brain Res Mol Brain Res 74:167–174
14. Shumay E, Fowler JS, Volkow ND (2010) Genomic features of the human dopamine transporter gene and its potential epigenetic States: implications for phenotypic diversity. Plos One 5:e11067
15. Martinat C, Bacci JJ, Leete T, Kim J, Vanti WB, Newman AH, Cha JH, Gether U, Wang H, Abeliovich A (2006) Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc Natl Acad Sci USA 103:2874–2879
16. Blake MC, Jambou RC, Swick AG, Kahn JW, Azizkhan JC (1990) Transcriptional initiation is controlled by upstream GC-box interactions in a TATAA-less promoter. Mol Cell Biol 10:6632–6641
17. Choi JK, Kim YJ (2008) Epigenetic regulation and the variability of gene expression. Nat Genet 40:141–147
18. Wang Y, Leung FC (2004) An evaluation of new criteria for CpG islands in the human genome as gene markers. Bioinformatics 20:1170–1177
19. Hillemacher T, Frieling H, Hartl T, Wilhelm J, Kornhuber J, Bleich S (2009) Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. J Psychiatr Res 43:388–392
20. Kawarai T, Kawakami H, Yamamura Y, Nakamura S (1997) Structure and organization of the gene encoding human dopamine transporter. Gene 195:11–18
21. Holler M, Westin G, Jiricny J, Schaffner W (1988) Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 2:1127–1135
22. Wang J, Michelhaugh SK, Bannon MJ (2007) Valproate robustly increases Sp transcription factor-mediated expression of the dopamine transporter gene within dopamine cells. Eur J Neurosci 25:1982–1986
23. Hossain MM, Richardson JR (2011) Mechanism of pyrethroid pesticide-induced apoptosis: role of calpain and the ER stress pathway. Toxicol Sci 122:512–525
24. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−delta delta C(T)) method. Methods 25:402–408
25. Aranyi T, Faucheux BA, Khalfallah O, Vodjdani G, Biguet NF, Mallet J, Meloni R (2005) The tissue-specific methylation of the human tyrosine hydroxylase gene reveals new regulatory elements in the first exon. J Neurochem 94:129–139
26. Bence M, Koller J, Sasvari-Szekely M, Keszler G (2012) Transcriptional modulation of monoaminergic neurotransmission genes by the histone deacetylase inhibitor trichostatin A in neuroblastoma cells. J Neural Transm 119:17–24
27. Ma P, Schultz RM (2008) Histone deacetylase 1 (HDAC1) regulates histone acetylation, development, and gene expression in preimplantation mouse embryos. Dev Biol 319:110–120
28. Montgomery RL, Davis CA, Potthoff MJ, Haberland M, Fielitz J, Qi X, Hill JA, Richardson JA, Olson EN (2007) Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility. Genes Dev 21:1790–1802
29. Broide RS, Redwine JM, Aftahi N, Young W, Bloom FE, Winrow CJ (2007) Distribution of histone deacetylases 1–11 in the rat brain. J Mol Neurosci 31:47–58
30. Robert MF, Morin S, Beaulieu N, Gauthier F, Chute IC, Barsalou A, MacLeod AR (2003) DNMT1 is required to maintain CpG methylation and aberrant gene silencing in human cancer cells. Nat Genet 33:61–65
31. Volpicelli F, De Gregorio R, Pulcrano S, Perrone-Capano C, di Porzio U, Bellenchi GC (2012) Direct regulation of Pitx3 expression by Nurr1 in culture and in developing mouse midbrain. Plos One 7:e30661
32. Aarnisalo P, Kim CH, Lee JW, Perlmann T (2002) Defining requirements for heterodimerization between the retinoid X receptor and the orphan nuclear receptor Nurr1. J Biol Chem 277:35118–35123
33. Wang J, Bannon MJ (2005) Sp1 and Sp3 activate transcription of the human dopamine transporter gene. J Neurochem 93:474–482
34. Hwang DY, Hong S, Jeong JW, Choi S, Kim H, Kim J, Kim KS (2009) Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. J Neurochem 111:1202–1212
35. Zhao Y, Xiong N, Liu Y, Zhou Y, Li N, Qing H, Lin Z (2013) Human dopamine transporter gene: differential regulation of 18-kb haplotypes. Pharmacogenomics 14:1481–1494
36. He XB, Yi SH, Rhee YH, Kim H, Han YM, Lee SH, Lee H, Park CH, Lee YS, Richardson E, Kim BW (2011) Prolonged membrane depolarization enhances midbrain dopamine neuron differentiation via epigenetic histone modifications. Stem Cells 29:1861–1873